UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 18, 2017
Accession Number: 0001193125-17-226254
Submission Type: POS AM
CIK: 0001390478
Company Name: Galena Biopharma, Inc.
File Number: 333-213908